Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis
Abstract
:1. Introduction
2. Results and Discussion
2.1. Wastewater Grab Samples
2.2. Twenty-Four Hour Composite Wastewater Samples
2.3. Comparison of Grab Samples and 24 h Composite Samples
3. Materials and Methods
3.1. Reagents and Materials
3.2. Sample Preparation
3.3. Instrumental Settings
3.4. Sampling
3.4.1. Wastewater Grab Samples
3.4.2. Twenty-Four Hour Composite Wastewater Samples
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- EMCDDA. European Drug Report 2022; Publications of of the European Union: Lisbon, Portugal, 2022. [Google Scholar]
- EMCDDA. European Drug Report 2023; Publications of of the European Union: Lisbon, Portugal, 2023. [Google Scholar]
- Wilms, W.; Woźniak-Karczewska, M.; Corvini, P.F.; Chrzanowski, Ł. Nootropic drugs: Methylphenidate, modafinil and piracetam—Population use trends, occurrence in the environment, ecotoxicity and removal methods—A review. Chemosphere 2019, 233, 771–785. [Google Scholar] [CrossRef] [PubMed]
- Fox, T.P.; Oliver, G.; Ellis, S.M. The destructive capacity of drug abuse: An overview exploring the harmful potential of drug abuse both to the individual and to society. ISRN Addict. 2013, 2013, 450348. [Google Scholar] [CrossRef] [PubMed]
- Ort, C.; van Nuijs, A.L.; Berset, J.D.; Bijlsma, L.; Castiglioni, S.; Covaci, A.; de Voogt, P.; Emke, E.; Fatta-Kassinos, D.; Griffiths, P.; et al. Spatial differences and temporal changes in illicit drug use in Europe quantified by wastewater analysis. Addiction 2014, 109, 1338–1352. [Google Scholar] [CrossRef] [PubMed]
- Meyer, M.R.; Vollerthun, T.; Hasselbach, R. Prevalence and distribution patterns of amphetamine and methamphetamine consumption in a federal state in southwestern Germany using wastewater analysis. Drug Alcohol Depend. 2015, 156, 311–314. [Google Scholar] [CrossRef] [PubMed]
- Ort, C.; Lawrence, M.G.; Rieckermann, J.; Joss, A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: Are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44, 6024–6035. [Google Scholar] [CrossRef] [PubMed]
- EMCDDA. Wastewater Analysis and Drugs—A European Multi-City Study; Publications of of the European Union: Lisbon, Portugal, 2024. [Google Scholar]
- Frankenfeld, F.; Wagmann, L.; Jacobs, C.M.; Meyer, M.R. Quantitative analysis of drugs of abuse and cognitive enhancers in influent wastewater by means of two chromatographic methods. Drug Test. Anal. 2023. [Google Scholar] [CrossRef] [PubMed]
- Helfer, A.G.; Meyer, M.R.; Michely, J.A.; Maurer, H.H. Direct analysis of the mushroom poisons alpha- and beta-amanitin in human urine using a novel on-line turbulent flow chromatography mode coupled to liquid chromatography-high resolution-mass spectrometry/mass spectrometry. J. Chromatogr. A 2014, 1325, 92–98. [Google Scholar] [CrossRef] [PubMed]
- Letzel, M.; Weiss, K.; Schüssler, W.; Sengl, M. Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system. Chemosphere 2010, 81, 1416–1422. [Google Scholar] [CrossRef] [PubMed]
- Castiglioni, S.; Bijlsma, L.; Covaci, A.; Emke, E.; Hernández, F.; Reid, M.; Ort, C.; Thomas, K.V.; van Nuijs, A.L.N.; de Voogt, P.; et al. Evaluation of uncertainties associated with the determination of community drug use through the measurement of sewage drug biomarkers. Environ. Sci. Technol. 2013, 47, 1452–1460. [Google Scholar] [CrossRef] [PubMed]
- van Nuijs, A.L.; Abdellati, K.; Bervoets, L.; Blust, R.; Jorens, P.G.; Neels, H.; Covaci, A. The stability of illicit drugs and metabolites in wastewater, an important issue for sewage epidemiology? J. Hazard. Mater. 2012, 239–240, 19–23. [Google Scholar] [CrossRef] [PubMed]
- Ludwig, W.D.; Mühlbauer, B.; Seifert, R. Arzneiverordnungs-Report 2023; Springer: Berlin, Germany, 2023. [Google Scholar]
- Finger, G.; Silva, E.R.; Falavigna, A. Use of methylphenidate among medical students: A systematic review (1992). Rev. Assoc. Med. Bras. 2013, 59, 285–289. [Google Scholar] [CrossRef] [PubMed]
- DVGW. Drug Residues in the Water Cycle; an Assessment from the Perspective of Drinking Water Supply; DVGW information WATER No. 54; Deutscher Verein des Gas- und Wasserfachs: Bonn, Germany, 2015. [Google Scholar]
- Zuccato, E.; Chiabrando, C.; Castiglioni, S.; Bagnati, R.; Fanelli, R. Estimating community drug abuse by wastewater analysis. Environ. Health Perspect. 2008, 116, 1027–1032. [Google Scholar] [CrossRef] [PubMed]
- van Nuijs, A.L.; Castiglioni, S.; Tarcomnicu, I.; Postigo, C.; Lopez de Alda, M.; Neels, H.; Zuccato, E.; Barcelo, D.; Covaci, A. Illicit drug consumption estimations derived from wastewater analysis: A critical review. Sci. Total Environ. 2011, 409, 3564–3577. [Google Scholar] [CrossRef] [PubMed]
- Castiglioni, S.; Bagnati, R.; Melis, M.; Panawennage, D.; Chiarelli, P.; Fanelli, R.; Zuccato, E. Identification of cocaine and its metabolites in urban wastewater and comparison with the human excretion profile in urine. Water Res. 2011, 45, 5141–5150. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Frankenfeld, F.; Wagmann, L.; Jacobs, C.M.; Meyer, M.R. Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis. Molecules 2024, 29, 3870. https://doi.org/10.3390/molecules29163870
Frankenfeld F, Wagmann L, Jacobs CM, Meyer MR. Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis. Molecules. 2024; 29(16):3870. https://doi.org/10.3390/molecules29163870
Chicago/Turabian StyleFrankenfeld, Fabian, Lea Wagmann, Cathy M. Jacobs, and Markus R. Meyer. 2024. "Prevalence of Drugs of Abuse and Cognitive Enhancer Consumption Monitored in Grab Samples and Composite Wastewater via Orbitrap Mass Spectrometry Analysis" Molecules 29, no. 16: 3870. https://doi.org/10.3390/molecules29163870